Growth appetite Sincerus Pharmaceuticals is expanding its Fort Lauderdale manufacturing campus and hiring additional staff, signaling a scaling phase with increased demand for custom dermatology medications—an opportunity to engage with procurement and manufacturing operations for long-term supply agreements.

Dermatology focus The company specializes in custom medicines for dermatologists and patient-specific formulations, indicating potential collaborations with dermatology clinics, specialty pharmacies, and contract manufacturing organizations (CMOs) to support personalized skin therapies.

Midmarket footprint With 51-200 employees and revenue in the $1M–$10M range, Sincerus sits in a growth-oriented midmarket segment that may benefit from scalable distribution partners, regional distributors, and channel partnerships to accelerate market reach.

Tech enabled Leveraging AWS, NetSuite, and other cloud-based tools, the company values scalable operations and data-driven processes—an opening to offer integration services, ERP optimization, or digital invoice-to-cash solutions to streamline supply and compliance.

Investment signals Recent funding and modest capital, combined with notable headcount growth, suggest a willingness to partner on strategic initiatives, including new product launches, white-labeling, or collaboration on regulatory submissions for dermatology-focused formulations.